Clinical trial
The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation
NCT05995093 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2022
- Completion date
- June 30, 2024
- Enrollment
- 462 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.